Nitrates in combination with hydralazine in cardiorenal syndrome: a randomized controlled proof‐of‐concept study

Abstract Aims Cardiorenal syndrome (CRS) is a common problem of great morbidity and mortality. Hydralazine–isosorbide dinitrate (H‐ISDN) may be used in renal failure and may improve exercise capacity in heart failure (HF). Our proof‐of‐concept study aimed to evaluate early evidence of efficacy, safe...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Shir Lynn Lim, Mihir Gandhi, Kai Lee Woo, Horng Ruey Chua, Yoke Ching Lim, David K.L. Sim, Sheldon S.G. Lee, Yee Leong Teoh, Arthur Mark Richards, Carolyn S.P. Lam
Format:	Artigo
Jezik:	Inglês
Izdano:	Oxford University Press 2020-12-01
Serija:	ESC Heart Failure
Teme:	Cardiorenal syndrome Hydralazine Isosorbide dinitrate Exercise capacity Endothelial function
Online dostop:	https://doi.org/10.1002/ehf2.13076
Oznake:	Označite Brez oznak, prvi označite!